Results 21 to 30 of about 8,472,955 (236)

Senescent Vascular Smooth Muscle Cells Drive Inflammation Through an Interleukin-1α-Dependent Senescence-Associated Secretory Phenotype. [PDF]

open access: yes, 2015
OBJECTIVE: Vascular smooth muscle cells (VSMCs) that become senescent are both present within atherosclerotic plaques and thought to be important to the disease process.
Sarah E. Gardner   +3 more
core   +2 more sources

Targeting the senescence-associated secretory phenotype in cancer therapy

open access: yes, 2023
The current main strategy in the treatment of cancer is to target rapidly dividing cells, which induces DNA damage and promotes senescence in both cancerous and non-malignant cells alike.
Niamh Kerslake (16845207)
core   +3 more sources

Redox control of senescence and age-related disease

open access: yesRedox Biology, 2017
The signaling networks that drive the aging process, associated functional deterioration, and pathologies has captured the scientific community's attention for decades.
Akshaya Chandrasekaran   +2 more
doaj   +1 more source

Effect of menopausal hormone therapy on proteins associated with senescence and inflammation

open access: yesPhysiological Reports, 2020
Background Estrogen may inhibit cell senescence that contributes to age‐related disorders. This study determined the effects of menopausal hormone treatments on circulating levels of markers of cell senescence.
Laura Faubion   +7 more
doaj   +1 more source

Identification and study of a role for toll-like receptors in oncogene-induced senescence

open access: yes, 2018
Oncogene-induced senescence (OIS) is a fail-safe mechanism activated to halt the proliferation of cells at risk of malignant transformation. It is a cell cycle arrest program of biological changes to the cell comprising of the activation of tumour ...
Hari, Priya
core   +3 more sources

Elucidating Proteoform Dynamics Underlying the Senescence Associated Secretory Phenotype

open access: yes, 2020
Primary diploid cells exit the cell cycle in response to exogenous stress or oncogene activation through a process known as cellular senescence. This cell-autonomous tumor-suppressive mechanism is also a major mechanism operative in organismal aging.
Peter F. Doubleday (8364153)   +2 more
core   +4 more sources

The Senescence-Associated Secretory Phenotype Promotes Benign Prostatic Hyperplasia [PDF]

open access: yes, 2014
Benign prostatic hyperplasia (BPH) is characterized by increased tissue mass in the transition zone of the prostate, which leads to obstruction of urine outflow and considerable morbidity in a majority of older men.
Vital, Paz   +3 more
core   +1 more source

Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy

open access: yesFrontiers in Oncology, 2018
In addition to promoting various forms of cell death, most conventional anti-tumor therapies also promote senescence. There is now extensive evidence that therapy-induced senescence (TIS) might be transient, raising the concern that TIS could represent ...
Tareq Saleh   +9 more
doaj   +1 more source

Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro

open access: yesCellular & Molecular Biology Letters, 2021
Background Various types of normal and cancer cells undergo senescence in response to carboplatin and paclitaxel, which are considered the gold standard treatments in ovarian cancer management.
Paweł Uruski   +8 more
doaj   +1 more source

Senescence and SASP Are Potential Therapeutic Targets for Ischemic Stroke

open access: yesPharmaceuticals
Aging is a known co-morbidity of ischemic stroke with its risk and severity increasing every year past 55+. While many of the current stroke therapies have shown success in reducing mortality, post-stroke morbidity has not seen the same substantial ...
Blake Ouvrier   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy